Cyclo(Arg-Gly-Asp-D-Phe-Val) TFA is primarily used in biomedical research due to its role as a potent integrin inhibitor. It specifically targets and binds to integrin receptors, which are crucial for cell adhesion and signaling processes. This makes it valuable in studying cancer metastasis, as it can inhibit tumor cell migration and invasion by blocking integrin-mediated pathways. Additionally, it is utilized in angiogenesis research to understand and control the formation of new blood vessels, which is significant in both cancer progression and wound healing. Its application extends to drug development, where it serves as a model compound for designing therapies aimed at modulating integrin activity in various diseases.